Abametapir and Elexacaftor: Interaction Details

Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Abametapir

We don't have a drug information page for Abametapir because it is no longer sold in the US: the FDA lists every approved version as discontinued. Have a question about Abametapir? Ask a pharmacist, free →

Elexacaftor

We don't have a drug information page for Elexacaftor yet. Have a question about Elexacaftor? Ask a pharmacist, free →

What Happens When You Take Abametapir With Elexacaftor

What can happen when they are taken together (rated Major)

Increased exposure of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Do not administer CYP3A4 substrates during the 2 weeks that follow abametapir application. When avoiding these substrates is not possible, refrain from using abametapir instead.1

The Abametapir and Elexacaftor Interaction, Explained

Here's what's going on. Abametapir is a lotion used to treat head lice. Even though you put it on your scalp, a little can get into your body and briefly slow down a liver enzyme called . That enzyme is one of the main ways your body breaks down elexacaftor (part of your cystic fibrosis medicine).

When that enzyme is slowed, elexacaftor can build up higher than usual, which could mean more side effects. This effect is expected to be strongest right after the lice treatment and can linger for about two weeks. The good news: this is very manageable. Please talk with your pharmacist or doctor before using a lice product so they can plan the safest timing for you.

Mechanism: Abametapir is a potent . Elexacaftor is a CYP3A4 , so co-exposure is expected to reduce its and increase systemic exposure (higher /).

  • Direction: increased elexacaftor exposure and potential for enhanced/adverse effects.
  • Onset: rapid; can persist for approximately 2 weeks after a single topical application.
  • Evidence: theoretical.
  • Management: Avoid CYP3A4 substrates, including elexacaftor, within 2 weeks after applying abametapir. If is unavoidable, avoid abametapir. If exposure occurs, monitor for elexacaftor-related adverse effects and individualize per the care team.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Abametapir and Elexacaftor Interact

The likely mechanism

of -mediated by abametapir

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Abametapir and Elexacaftor Interaction

The key is timing. Because abametapir can raise elexacaftor levels for about two weeks after it is applied, the documented guidance is to avoid combining them during that window.

  • Do not stop your cystic fibrosis medicine on your own. Keep taking it as prescribed.
  • Before using any head lice treatment, tell your pharmacist or prescriber that you take elexacaftor.
  • Your care team may choose a different lice treatment, adjust timing, or monitor you more closely for side effects.
  • If you have already used both, contact your care team and watch for any new or stronger side effects.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Abametapir or Elexacaftor need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Abametapir and Elexacaftor: Common Questions

How serious is the Abametapir and Elexacaftor interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Abametapir and Elexacaftor interaction managed?

The key is timing. Because abametapir can raise elexacaftor levels for about two weeks after it is applied, the documented guidance is to avoid combining them during that window. Do not stop your cystic fibrosis medicine on your own. Keep taking it as prescribed. Before using any head lice treatment, tell your pharmacist or prescriber that you take elexacaftor. Your care team may choose a differen… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Abametapir and Elexacaftor Interaction

Ask in your own words about taking Abametapir and Elexacaftor together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: XEGLYZE(TM) topical lotion, abametapir topical lotion. Dr Reddy’s Laboratories Inc (per FDA), Princeton, NJ, 2020. DailyMed
Was this write-up helpful?

Other Serious Interactions of Abametapir and Elexacaftor

Also serious with Abametapir

Also serious with Elexacaftor

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Abametapir

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.